Literature DB >> 20037604

Krüppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs.

Yu Liu1, Jin-kun Wen, Li-hua Dong, Bin Zheng, Mei Han.   

Abstract

AIM: To elucidate how krüppel-like factor (KLF5) activates cyclin D1 expression in Ang II-induced vascular smooth muscle cells (VSMC) proliferation.
METHODS: An adenoviral vector containing the full-length cDNA of KLF5 and a recombinant plasmid expressing c-Jun were constructed. MTT assay and flow cytometric analysis were used to determine the effect of Ang II on cell growth. The luciferase assay and chromatin immunoprecipitation were used to detect the relationship between KLF5 and c-Jun in transactivation of cyclin D1 gene expression.
RESULTS: Ang II upregulated the expression of KLF5 with concurrent acceleration of the cell cycle progression in VSMCs. Ang II induced KLF5 activation via the ERK and p38 MAPK pathways triggered by AT-1 receptor. High DNA binding activity and functional interaction of KLF5 and c-Jun were found in Ang II-induced VSMCs. Cotransfection of KLF5 and c-Jun expression vectors significantly increased cyclin D1 promoter activity.
CONCLUSION: KLF5 is a downstream signal of the ERK 1/2 and p38 MAPK pathways, and activates the transcription of cyclin D1 gene via functional interaction with c-Jun in Ang II-induced VSMC proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20037604      PMCID: PMC4002698          DOI: 10.1038/aps.2009.185

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  28 in total

1.  Functional interaction of the DNA-binding transcription factor Sp1 through its DNA-binding domain with the histone chaperone TAF-I.

Authors:  Toru Suzuki; Shinsuke Muto; Saku Miyamoto; Kenichi Aizawa; Masami Horikoshi; Ryozo Nagai
Journal:  J Biol Chem       Date:  2003-05-19       Impact factor: 5.157

2.  Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain.

Authors:  Saku Miyamoto; Toru Suzuki; Shinsuke Muto; Kenichi Aizawa; Akatsuki Kimura; Yoshiko Mizuno; Tomoko Nagino; Yasushi Imai; Naruhiko Adachi; Masami Horikoshi; Ryozo Nagai
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function.

Authors:  Zhiping Zhang; Christina T Teng
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

4.  Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation.

Authors:  Céline Dugourd; Marianne Gervais; Pierre Corvol; Catherine Monnot
Journal:  Hypertension       Date:  2003-03-03       Impact factor: 10.190

5.  Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.

Authors:  M Kyaw; M Yoshizumi; K Tsuchiya; K Kirima; T Tamaki
Journal:  Hypertens Res       Date:  2001-05       Impact factor: 3.872

6.  Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK.

Authors:  S Eguchi; P J Dempsey; G D Frank; E D Motley; T Inagami
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

Review 7.  Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.

Authors:  S Kim; H Iwao
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

8.  Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.

Authors:  Mandayam O Nandan; Hong S Yoon; Weidong Zhao; Lillian A Ouko; Sengthong Chanchevalap; Vincent W Yang
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

9.  Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells.

Authors:  Ming He; Mei Han; Bin Zheng; Ya-Nan Shu; Jin-Kun Wen
Journal:  J Biochem       Date:  2009-07-23       Impact factor: 3.387

10.  Intestinal tumor progression is associated with altered function of KLF5.

Authors:  Nicholas W Bateman; Dongfeng Tan; Richard G Pestell; Jennifer D Black; Adrian R Black
Journal:  J Biol Chem       Date:  2004-01-15       Impact factor: 5.157

View more
  22 in total

1.  ML264, A Novel Small-Molecule Compound That Potently Inhibits Growth of Colorectal Cancer.

Authors:  Ainara Ruiz de Sabando; Chao Wang; Yuanjun He; Mónica García-Barros; Julie Kim; Kenneth R Shroyer; Thomas D Bannister; Vincent W Yang; Agnieszka B Bialkowska
Journal:  Mol Cancer Ther       Date:  2015-11-30       Impact factor: 6.261

2.  Krüpple-like factor 5 is required for proper maintenance of adult intestinal crypt cellular proliferation.

Authors:  Kristin N Bell; Noah F Shroyer
Journal:  Dig Dis Sci       Date:  2014-07-29       Impact factor: 3.199

Review 3.  Krüppel-like factors and vascular wall homeostasis.

Authors:  Yanbo Fan; Haocheng Lu; Wenying Liang; Wenting Hu; Jifeng Zhang; Y Eugene Chen
Journal:  J Mol Cell Biol       Date:  2017-10-01       Impact factor: 6.216

4.  The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells.

Authors:  Joshua M Boucher; Sarah M Peterson; Sumithra Urs; Chunxiang Zhang; Lucy Liaw
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

5.  miR-29a regulates vascular neointimal hyperplasia by targeting YY1.

Authors:  Yu Zhang; Yong Hui Li; Chao Liu; Chan-Juan Nie; Xin-Hua Zhang; Cui-Ying Zheng; Wen Jiang; Wei-Na Yin; Ming-Hui Ren; Yu-Xin Jin; Shu-Feng Liu; Bin Zheng; Jin-Kun Wen
Journal:  Cell Prolif       Date:  2016-12-02       Impact factor: 6.831

6.  Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells.

Authors:  Xin Li; Baotong Zhang; Qiao Wu; Xinpei Ci; Ranran Zhao; Zhiqian Zhang; Siyuan Xia; Dan Su; Jie Chen; Gui Ma; Liya Fu; Jin-Tang Dong
Journal:  Int J Cancer       Date:  2014-06-28       Impact factor: 7.396

7.  CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.

Authors:  Qiao Wu; Changying Fu; Menglin Li; Juan Li; Zhigui Li; Leilei Qi; Xinpei Ci; Gui Ma; Ang Gao; Xing Fu; Jun A; Na An; Mingcheng Liu; Yixiang Li; Jamie L King; Liya Fu; Baotong Zhang; Jin-Tang Dong
Journal:  Int J Cancer       Date:  2018-10-26       Impact factor: 7.396

8.  Kruppel-like factor 5 controls villus formation and initiation of cytodifferentiation in the embryonic intestinal epithelium.

Authors:  Sheila M Bell; Liqian Zhang; Yan Xu; Valerie Besnard; Susan E Wert; Noah Shroyer; Jeffrey A Whitsett
Journal:  Dev Biol       Date:  2012-12-22       Impact factor: 3.582

9.  MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5.

Authors:  Jian-Yong Liu; Jian-Bin Lu; Yue Xu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

Review 10.  Current knowledge of Krüppel-like factor 5 and vascular remodeling: providing insights for therapeutic strategies.

Authors:  Ziyan Xie; Junye Chen; Chenyu Wang; Jiahao Zhang; Yanxiang Wu; Xiaowei Yan
Journal:  J Mol Cell Biol       Date:  2021-05-07       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.